Skip to main content

Find Clinical Trials

Clinical trial condition

HIV

Explore clinical trials studying HIV. Study availability and eligibility vary by location and protocol.

1,761 public trials 191 recruiting studies

Refine in advanced search Browse all conditions

HIV trial results

Completed

A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV)

NCT01445223

Conditions: HIV
Locations: Department of Infectious Diseases Gothenburg, Goteborg, Sweden

View Trial Details

Completed

Integrating Buprenorphine Into the SFGH AIDS Program

NCT00263458

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Buprenorphine, +21 more
Locations: UCSF Positive Health Program San Francisco, California, United States

View Trial Details

Completed

Cameroon Mobile Phone SMS Trial

NCT01247181

Conditions: Acquired Immunodeficiency Syndrome, Adherence, Behavior, +20 more
Locations: Yaounde Central Hospital Accredited Treatment Centre Yaoundé, Centre Region, Cameroon

View Trial Details

Completed

Study of SystemCHANGE-HIV

NCT01256814

Conditions: Acquired Immunodeficiency Syndrome, Behavior, Blood-Borne Infections, +16 more
Locations: Case Western Reserve University Cleveland, Ohio, United States

View Trial Details

Completed

Targeting Interventions at Venues Where Risk of HIV Transmission is High

NCT01423357

Conditions: HIV
Locations: Dambwa Livingstone, Zambia

Maramba Livingstone, Zambia

View Trial Details

Completed

TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

NCT00255099

Conditions: HIV
Locations: Not specified

View Trial Details

Completed

TMC114-C213: A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV.

NCT00650832

Conditions: HIV
Locations: Not specified

View Trial Details

Completed

TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.

NCT00767117

Conditions: HIV
Locations: Not specified

View Trial Details

Completed

TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.

NCT00740389

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +18 more
Locations: Not specified

View Trial Details

Completed

TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers.

NCT00744887

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
Locations: Not specified

View Trial Details